Brain-resident immune cells that have reached an old-age state called “senescence” secrete a protein that causes dysfunction in other brain cells, according to Weill Cornell Medicine researchers, a finding that could shed light on memory loss.
Researchers found that while the smoother, quieter ride of an electric bus was appealing to those who already rode public transportation, those advantages weren’t enough to lure drivers away from their cars.
Researchers have uncovered how a key Parkinson’s protein shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial.
The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Announced Aug. 5 at Cornell Tech, a research partnership will help neighborhoods in Brooklyn, Queens and the Bronx identify where new trees are needed most to improve public health.
A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine.
